2018-10-17T12:45:34-05:00 2017-12-31 560574444 CHERRY BEKAERT LLP 1111 METROPOLITAN AVE STE 900 CHARLOTTE NC 28204 990 2017-01-01 010648145 ORTHOCAROLINA RESEARCH INSTITUTE INC ORTH 7043232260 2001 VAIL AVENUE NO 300 CHARLOTTE NC 28207 CHRISTI CADD EXECUTIVE DIRECTOR 7043232260 2018-10-11 1 AMANDA ADAMS P00748038 7043771678 2017 2022-09-23 18:48:47Z CHRISTI CADD 2001 VAIL AVENUE NO 300 CHARLOTTE NC 28207 2348225 0 X WWW.ORTHOCAROLINARESEARCH.ORG X 2002 NC ORTHOCAROLINA RESEARCH INSTITUTE (THE "INSTITUTE OR "OCRI") IS A NON-PROFIT ORGANIZATION DEDICATED TO PROMOTE, DEVELOP AND CONDUCT STATE OF THE ART SCIENTIFIC RESEARCH AND EDUCATIONAL PROGRAMS FOR THE ADVANCEMENT OF ORTHOPAEDIC CARE. OCRI WORKS BOTH INDEPENDENTLY AS WELL AS IN COLLABORATION WITH UNIVERSITIES, HOSPITALS, PHARMACEUTICAL COMPANIES, HEALTHCARE DEVICE MANUFACTURERS AND OTHER ACADEMIC AND RESEARCH ORGANIZATIONS TO FURTHER PROMOTE THE MISSION. 15 15 0 6 0 0 945878 1128769 1067909 878272 129268 341184 0 0 2143055 2348225 0 0 0 0 1131742 0 0 0 8567 731942 1851277 1863684 1851277 279371 496948 2801814 3412571 333535 396799 2468279 3015772 X THE INSTITUTE'S MISSION AND PRIORITIES ARE CENTRALLY FOCUSED ON: (1) IMPROVED PATIENT CARE, (2) HIGH QUALITY RESEARCH TO DEVELOP NEW AND INNOVATIVE ORTHOPAEDIC DEVICES AND TECHNOLOGIES, AND (3) COLLABORATIVE AND MULTIDISCIPLINE FORUMS TO FURTHER ENHANCE STATE-OF-THE-ART MEDICAL HEALTHCARE. THE INSTITUTE IS CURRENTLY PARTICIPATING IN 25 ON-GOING FDA REGULATED CLINICAL TRIALS AND APPROXIMATELY 213 SCIENTIFIC OUTCOMES STUDIES. 0 0 1200166 863797 THE INSTITUTE'S MISSION AND PRIORITIES ARE CENTRALLY FOCUSED ON (1) IMPROVED ORTHOPEDIC PATIENT CARE (2) HIGH QUALITY EVIDENCE-BASED RESEARCH TO DEVELOP NEW AND INNOVATIVE ORTHOPEDIC DEVICES AND TECHNOLOGIES WHOSE GOAL IS TO ANSWER CLINICAL QUESTIONS FOR IMPROVED OUTCOMES. THE INSTITUTE IS CURRENTLY LEADING 30 ONGOING FDA-REGULATED CLINICAL TRIALS AND APPROXIMATELY 215 INVESTIGATOR-INITIATED SCIENTIFIC ACADEMIC STUDIES. RESEARCH IS DISSEMINATED THROUGH PEER REVIEWED JOURNAL PUBLICATIONS WITH GREATER THAN 70 PUBLICATIONS ANNUALLY. 95873 14475 THE INSTITUTE'S MISSION IS FOCUSED ON ADVANCING BOTH RESEARCH AND EDUCATION IN ORTHOPEDICS. THE ORTHOCAROLINA RESEARCH INSTITUTE HOSTS AN EDUCATIONAL CME (CONTINUING MEDICAL EDUCATION) SYMPOSIUM FOR 350-400 ORTHOPEDIC PROVIDERS AND ALLIED HEALTH CARE PROFESSIONALS EACH YEAR KNOWN AS OSCAR MILLER DAY. THIS SYMPOSIUM IS OVER 35 YEARS OLD, IS MARKETED TO THE SOUTH EASTERN US AND ROTATES TOPICS ANNUALLY. 95549 OPERATION WALK CAROLINAS IS A JOINT EFFORT BETWEEN TEAMS AT ORTHOCAROLINA, CAROLINAS HEALTHCARE AND NOVANT HEALTH. THIS PROGRAM PROVIDES FREE SURGICAL TREATMENT TO PATIENTS IN DEVELOPING COUNTRIES AND EDUCATION FOR IN-COUNTRY ORTHOPEDIC SURGEONS, NURSES, PHYSICAL THERAPISTS AND OTHER HEALTHCARE PROFESSIONALS ON THE MOST ADVANCED TREATMENTS AND SURGICAL TECHNIQUES FOR DISEASES OF THE HIP AND KNEE JOINTS. DURING 2017, A GROUP WAS SENT TO CUBA TO PROVIDE SURGICAL TREATMENTS TO UNDER-PRIVILEGED PATIENTS. 1391588 1 1 0 0 0 0 0 0 0 0 1 1 0 0 0 1 1 0 0 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 29 0 1 0 0 0 0 0 0 0 0 0 0 0 X 15 15 0 0 0 0 0 0 0 1 1 1 0 1 1 1 1 1 1 1 1 0 NC X CHRISTI CADD 7043232260 2001 VAIL AVENUE STE 300 CHARLOTTE NC 28207 X WILLIAM GRIFFIN MD CHAIRMAN 1.00 X X 0 0 0 ROBERT ANDERSON DIRECTOR 0.25 X 0 0 0 WALTER B BEAVER MD DIRECTOR 0.25 X 0 0 0 BRANDON BOYD DIRECTOR 0.01 X 0 0 0 PATRICK M CONNOR MD DIRECTOR 0.01 X 0 0 0 CHARLES EAST III DIRECTOR 0.25 X 0 0 0 KENT ELLINGTON MD DIRECTOR 0.25 X 0 0 0 MR JOHN L FRALEY JR DIRECTOR 0.01 X 0 0 0 GLENN GASTON MD DIRECTOR 0.25 X 0 0 0 HARVEY GANTT DIRECTOR 0.01 X 0 0 0 MORRY JOHNSTON DIRECTOR 0.01 X 0 0 0 FRED R JONES DIRECTOR 0.25 X 0 0 0 MR RICHARD E THIGPEN DIRECTOR 0.01 X 0 0 0 MR WESLEY WALLS DIRECTOR 0.01 X 0 0 0 VELVA WOOLLEN DIRECTOR 0.01 X 0 0 0 CHRISTI CADD EXECUTIVE DIRECTOR 40.00 X 113699 0 40461 113699 0 40461 1 0 1 0 0 1128769 1128769 RESEARCH 900099 863797 863797 MILLER DAY TICKETS 900099 14475 14475 878272 341184 341184 2348225 878272 0 341184 464 464 13775 13775 15442 15442 823 823 54058 50441 3617 8216 8216 35384 35384 84705 73604 11101 9900 4950 4950 23172 23172 SHARED SERVICES 1190811 961435 229376 STUDY EXPENSES 235257 235257 OSCAR MILLER DAY 95837 95837 EQUIPMENT 51938 51938 31495 25455 6040 1851277 1391588 451122 8567 260214 309887 50545 112011 291951 268027 63378 43578 29700 19800 2153404 2686846 16000 16000 2801814 3412571 282990 246799 150000 50545 0 333535 396799 X 2338216 2707508 130063 308264 2468279 3015772 2801814 3412571 X 496948 50545 X 0 1 X 1 0 X 570855 491782 434323 945878 1128769 3571607 1084526 874328 992667 1067909 878272 4897702 1655381 1366110 1426990 2013787 2007041 8469309 278627 334287 254419 753833 814292 2435458 88266 50276 367627 506169 278627 334287 342685 804109 1181919 2941627 5527682 20742 42371 84426 129268 341184 617991 20742 42371 84426 129268 341184 617991 1676123 1408481 1511416 2143055 2348225 9087300 0.60830 0.71220 0.06800 0.03780 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 13878 13878 0 49500 29700 19800 19800 POOLED INV FUND - FFTC 2686846 F 2686846 X 2337921 5138 5138 2332783 15442 15442 2348225 1840973 5138 5138 1835835 15442 15442 1851277 PART X, LINE 2: THE INSTITUTE ADOPTED THE FINANCIAL ACCOUNTING STANDARDS BOARD ("FASB") GUIDANCE ON ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES. THE GUIDANCE CLARIFIES THE ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES RECOGNIZED IN AN ENTITY'S FINANCIAL STATEMENTS BY PRESCRIBING A RECOGNITION THRESHOLD AND MEASUREMENT ATTRIBUTE FOR THE FINANCIAL STATEMENT RECOGNITION AND MEASUREMENT OF A TAX POSITION TAKEN OR EXPECTED TO BE TAKEN. THE INSTITUTE'S POLICY IS TO RECORD A LIABILITY FOR ANY TAX POSITION TAKEN THAT IS BENEFICIAL TO THE INSTITUTE, INCLUDING ANY RELATED INTEREST AND PENALTIES, WHEN IT IS MORE LIKELY THAN NOT THE POSITION TAKEN BY MANAGEMENT WITH RESPECT TO A TRANSACTION OR CLASS OF TRANSACTIONS WILL BE OVERTURNED BY A TAXING AUTHORITY UPON EXAMINATION. MANAGEMENT BELIEVES THERE ARE NO SUCH POSITIONS AS OF DECEMBER 31, 2017 AND, ACCORDINGLY, NO LIABILITY HAS BEEN ACCRUED. CENTRAL AMERICA AND THE CARIBBEAN 0 0 PROGRAM SERVICES THIS PROGRAM PROVIDES FREE SURGICAL TREATMENT TO PATIENTS AND EDUCATION FOR IN-COUNTRY ORTHOPEDIC SURGEONS, NURSES, PHYSICAL THERAPISTS AND OTHER HEALTHCARE PROFESSIONALS ON THE MOST ADVANCED TREATMENTS AND SURGICAL TECHNIQUES FOR DISEASES OF THE HIP AND KNEE JOINTS. 95549 0 0 0 0 0 0 95549 0 95549 0 0 0 0 0 0 PART I, LINE 3: THE AMOUNT REPORTED IN PART I FOR EXPENDITURES WAS CALCULATED USING THE ACCRUAL METHOD OF ACCOUNTING. 0 0 0 0 0 0 0 0 0 CHRISTI CADD EXECUTIVE DIRECTOR 102609 0 10800 0 290 0 3582 0 36879 0 154160 0 0 0 FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 IS EMAILED TO ALL BOARD MEMBERS FOR THEIR REVIEW PRIOR TO FILING. FORM 990, PART VI, SECTION B, LINE 12C DIRECTORS, OFFICERS AND KEY EMPLOYEES CERTIFY THAT THEY READ THE ORGANIZATION'S CONFLICT OF INTEREST POLICY AND HAVE DISCLOSED ANY RELATIONSHIPS WITH ANY OF THE ORGANIZATION'S CONTRACTING PARTIES ON THE ORGANIZATION'S CONFLICT OF INTEREST FORM. THE EXECUTIVE DIRECTOR REVIEWS THESE CERTIFIED FORMS, INCLUDING COMPARISONS TO THE PRIOR YEAR'S DISCLOSURES, AND CONFIRMS ANY CHANGES WITH THE SIGNERS. NO QUESTIONABLE RELATIONSHIP HAS BEEN NOTED OR BROUGHT TO THE ATTENTION OF THE APPROPRIATE GOVERNANCE GROUP. AT THE FEBRUARY MEETING OF THE FINANCE/AUDIT COMMITTEE, THE EXECUTIVE DIRECTOR REVIEWS WITH THE COMMITTEE THE COMPLIANCE STEPS TAKEN AND THE RESULTS FOR THE YEAR, AND CONFIRMS THAT NOTHING HAS BEEN BROUGHT TO HER ATTENTION DURING THE YEAR WHICH WOULD REQUIRE FURTHER EXAMINATION OF THE CURRENT CONFLICT OF INTEREST CERTIFICATIONS. THIS REVIEW IS INCLUDED AS PART OF THE COMMITTEE'S NORMAL REPORT TO THE BOARD REGARDING THE COMMITTEE'S ACTIVITIES. FORM 990, PART VI, SECTION B, LINE 15 THE EXECUTIVE COMMITTEE COMPLETES A PERFORMANCE EVALUATION AND ASSESSMENT OF SALARY FOR THE EXECUTIVE DIRECTOR ANNUALLY. THE EXECUTIVE COMMITTEE CONSISTS OF THE CHAIRMAN OF THE BOARD, CHAIRMAN OF THE RESEARCH ADVISORY COMMITTEE AND THE EXECUTIVE DIRECTOR. THE EXECUTIVE DIRECTOR IS A MEMBER OF THE EXECUTIVE COMMITTEE; HOWEVER, HAS NO VOTE WHEN IT COMES TO PERSONAL PERFORMANCE AND SALARY. THE ORTHOCAROLINA RESEARCH INSTITUTE SHARES HUMAN RESOURCE SERVICES WITH ORTHOCAROLINA, PA. THE ORTHOCAROLINA, PA HUMAN RESOURCE DEPARTMENT PERFORMS PERIODIC REVIEWS OF ALL POSITIONS TO ENSURE SALARIES ARE COMPETITIVE AND FAIR WITHIN THE MARKET. IT IS COMMON PRACTICE FOR SALARIES TO INCREASE 3-5% DEPENDING ON INDIVIDUAL PERFORMANCE ANNUALLY. THE EXECUTIVE DIRECTOR BUDGETS SALARY INCREASES ANNUALLY AND SHOULD A STAFF SALARY INCREASE GREATER THAN THE 3-5% EXPECTED RANGE, IT IS PRESENTED BEFORE THE EXECUTIVE COMMITTEE FOR APPROVAL. ALL SALARY ADJUSTMENTS MADE BY THE ORTHOCAROLINA RESEARCH INSTITUTE ARE DOCUMENTED AND SUBMITTED TO THE ORTHOCAROLINA PA, HUMAN RESOURCE DEPARTMENT FOR FINAL APPROVAL BEFORE SUBMITTING TO PAYROLL. FORM 990, PART VI, SECTION C, LINE 19 GOVERNING DOCUMENTS, POLICIES AND PROCEDURES AND FINANCIAL STATEMENTS ARE HELD IN THE OFFICE OF THE EXECUTIVE DIRECTOR. SUCH DOCUMENTS ARE AVAILABLE FOR REVIEW UPON REQUEST. FORM 990, PART VII, SECTION A, #16 THE INSTITUTE HAS AN AGREEMENT WITH AN UNRELATED ORGANIZATION TO SHARE EMPLOYEES. ALL PERSONS PROVIDING SERVICES TO THE INSTITUTE ARE EMPLOYEES OF THE UNRELATED ORGANIZATION. THE INSTITUTE REIMBURSES THE ORGANIZATION FOR THE SERVICES PROVIDED BY SUCH EMPLOYEES TO THE INSTITUTE. THIS AMOUNT HAS BEEN SHOWN IN PART IX AS "SHARED SERVICES EXPENSE." THE AMOUNTS SHOWN IN PART VII FOR CHRISTI CADD REFLECT THE AMOUNTS REIMBURSED BY THE INSTITUTE FOR HER SERVICES. FORM 990, PART XI, LINE 9: ADJUSTMENT TO REMOVE LIABILITY FOR FUNDS NO LONGER TREATED AS AGENCY FUNDS 50,545.